HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by Banco Bilbao Vizcaya Argentaria S.A.

Banco Bilbao Vizcaya Argentaria S.A. cut its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 4.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 29,213 shares of the company’s stock after selling 1,374 shares during the period. Banco Bilbao Vizcaya Argentaria S.A.’s holdings in HCA Healthcare were worth $8,772,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in HCA. Pinebridge Investments L.P. boosted its position in shares of HCA Healthcare by 38.9% during the fourth quarter. Pinebridge Investments L.P. now owns 95,849 shares of the company’s stock worth $28,769,000 after buying an additional 26,836 shares during the period. Crake Asset Management LLP raised its stake in shares of HCA Healthcare by 176.3% in the fourth quarter. Crake Asset Management LLP now owns 69,087 shares of the company’s stock valued at $20,736,000 after acquiring an additional 44,087 shares in the last quarter. Quantessence Capital LLC purchased a new stake in HCA Healthcare during the 4th quarter worth about $406,000. Khrom Capital Management LLC acquired a new position in shares of HCA Healthcare during the fourth quarter worth about $25,001,000. Finally, Eversept Partners LP grew its position in shares of HCA Healthcare by 36.2% in the 4th quarter. Eversept Partners LP now owns 175,808 shares of the company’s stock valued at $52,769,000 after buying an additional 46,724 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Stock Up 1.6 %

HCA opened at $341.28 on Friday. The company has a market cap of $84.02 billion, a price-to-earnings ratio of 15.53, a PEG ratio of 1.10 and a beta of 1.48. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The business’s fifty day moving average is $329.61 and its two-hundred day moving average is $332.87.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the prior year, the firm earned $5.90 EPS. Analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the company. Bank of America cut their target price on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a research report on Monday, January 27th. Truist Financial lowered their price target on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Royal Bank of Canada lowered their target price on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a research note on Monday, January 27th. Robert W. Baird reaffirmed a “neutral” rating and set a $336.00 price target (down from $396.00) on shares of HCA Healthcare in a report on Tuesday, April 15th. Finally, StockNews.com cut shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Wednesday, April 9th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $381.67.

Insider Buying and Selling at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the sale, the senior vice president now owns 15,412 shares in the company, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.30% of the stock is owned by insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.